Monte Rosa Therapeutics had a revenue of 12.77M in the quarter ending Sep 30, 2025, with -44.95%. This bring the company's revenue in the last twelve months to 181.54M, Decreased 2.00%. In the fiscal year ending Dec 31, 2024, Monte Rosa Therapeutics had annual revenue of 75.62M with Infinity% growth.